MONEY

Corcept therapeutics exec sells $509k in stock, buys options

Tomas Kauer - ModeratorTomas Kauer - Moderator
Oct 2, 2024 - 08:00
Corcept therapeutics exec sells $509k in stock, buys options
Read More

Tags:

Previous Article

Decoding the Synod on Synodality: CNA’s essential terminology guide

Next Article

Enliven Therapeutics CFO sells shares worth over $150k

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)

Aileron Therapeutics Completes Enrollment in Cohort 2 o...

Tomas Kauer - Mode... Sep 23, 2024

UCB Announces a Head-to-Head Study Evaluating BIMZELX ® (bimekizumab) versus SKYRIZI ® (risankizumab) in Active Psoriatic Arthritis

UCB Announces a Head-to-Head Study Evaluating BIMZELX ®...

Tomas Kauer - Mode... Sep 30, 2024

Vista Outdoor's Board of Directors Is Committed to Exploring All Opportunities to Maximize the Value of Revelyst, Including a Potential Sale

Vista Outdoor's Board of Directors Is Committed to Expl...

Tomas Kauer - Mode... Sep 19, 2024